Loading...

Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL 48€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  4. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  5. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  6. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  7. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  8. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  9. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  10. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  11. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  12. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  13. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  14. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  15. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  16. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  17. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  18. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  19. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  20. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  21. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  22. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  23. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  24. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  25. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  26. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  27. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  28. Chan L, et al. 2022. Cells. 12: . PubMed
  29. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  30. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  31. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  32. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  33. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  34. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  35. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  36. Zander R, et al. 2022. Immunity. 55:475. PubMed
  37. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  38. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  39. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  40. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  41. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  42. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  43. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  44. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  45. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  46. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  47. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  48. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  49. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  50. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  51. Wang H, et al. 2023. Nature. 615:339. PubMed
  52. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  53. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  54. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  55. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  56. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  57. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  58. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  59. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  60. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  61. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  62. Glowacki, R. W. P., Engelhart, M. J., et al. 2025. Microbiol Spectr. 13(10),e0341924. PubMed
  63. Finlin, B. S., Memetimin, H., et al. 2025. Mol Med. 31(1),313. PubMed
  64. Xiang, L., Jia, Z., et al. 2025. Stem Cell Res Ther. 16(1),636. PubMed
  65. Liu, M., Yu, Z., et al. 2025. Sci Adv. 11(46),eadz4847. PubMed
  66. Li, J., Cai, H., et al. 2025. NPJ Regen Med. 10(1),52. PubMed
  67. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  68. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  69. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  70. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  71. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  72. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  73. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  74. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  75. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  76. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  77. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  78. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  79. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  80. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  81. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  82. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  83. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  84. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  85. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  86. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  87. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  88. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  89. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  90. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  91. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  92. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  93. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  94. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  95. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  96. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  97. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  98. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  99. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  100. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  101. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  102. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  103. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  104. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  105. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  106. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  107. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  108. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  109. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  110. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  111. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  112. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  113. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  114. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  115. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  116. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  117. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  118. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  119. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  120. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  121. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  122. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  123. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  124. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  125. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  126. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  127. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  128. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  129. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  130. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  131. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  132. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  133. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  134. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  135. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  136. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  137. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  138. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  139. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  140. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  141. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  142. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  143. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  144. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  145. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  146. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  147. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  148. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  149. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  150. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  151. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  152. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  153. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  154. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  155. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  156. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  157. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  158. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  159. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  160. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  161. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  162. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  163. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  164. Ma K, et al. 2022. iScience. 25:104347. PubMed
  165. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  166. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  167. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  168. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  169. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  170. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  171. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  172. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  173. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  174. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  175. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  176. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  177. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  178. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  179. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  180. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  181. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  182. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  183. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  184. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  185. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  186. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  187. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  188. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  189. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  190. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  191. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  192. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  193. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  194. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  195. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  196. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  197. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  198. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  199. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  200. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  201. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  202. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  203. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  204. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  205. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  206. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  207. Wang X, et al. 2022. Elife. 11:. PubMed
  208. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  209. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  210. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  211. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  212. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  213. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  214. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  215. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  216. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  217. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  218. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  219. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  220. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account